Galina Gabriely

Galina Gabriely has a diverse work experience in the field of biomedical research and academia. Galina is currently working at Jounce Therapeutics, Inc. as a Principal Scientist since July 2022. Prior to this role, they were a Senior Scientist at the same company from July 2021 to June 2022.

Before joining Jounce Therapeutics, Inc., Galina worked as an Instructor at Harvard Medical School from December 2016 to July 2021. During this time, they gained valuable teaching and research experience.

Additionally, Galina worked as a Consultant at Tilos Therapeutics from October 2016 to May 2019, contributing their expertise to the company's projects.

Galina's career began at Brigham and Women's Hospital where they served as a Postdoctoral Fellow. Galina held two separate positions at the hospital from September 2007 to March 2011 and from April 2011 to November 2016, gaining extensive research experience in the field.

Prior to their work at Brigham and Women's Hospital, Galina was a Postdoctoral Fellow at the Weizmann Institute of Science from 2006 to 2007.

Galina'sacademic journey started at the Weizmann Institute of Science, Department of Molecular Genetics, where they pursued their Ph.D. studies from 2001 to 2006.

Overall, Galina Gabriely's work experience showcases their expertise and dedication in the biomedical research field, with notable positions at Jounce Therapeutics, Harvard Medical School, and Brigham and Women's Hospital.

Galina Gabriely earned their Master's degree in Cancer Biology from Tel Aviv University, which they attended from 1998 to 2000. Galina later pursued a Ph.D. in Molecular Genetics at the Weizmann Institute of Science, where they completed their studies from 2001 to 2006.